Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis.
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man.
Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening.
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.
[The comparative study of efficacy and tolerability of intramuscular introduction of beta-interferon-1a in adults and adolescents with remitting multiple sclerosis.]
Ximino
IL-1β induces hypomyelination in the periventricular white matter through inhibition of oligodendrocyte progenitor cell maturation via FYN/MEK/ERK signaling pathway in septic neonatal rats.
Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro.
Behçet's Disease Presenting with Acute Transverse Myelitis: MRI Findings and Review of the Nosology. A Case Report.
Physiotherapy as an immunoactive therapy? A pilot study.
Acute relapse after initiation of Siponimod in a patient with secondary progressive MS.
Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
New Drug Review 2010: Ustekinumab (Stelara, Centocor Ortho Biotech)
Multiple Sclerosis: Validation of MR Imaging for Quantification and Detection of Iron.
Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis.
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
Cognitive impairment as unusual first manifestation in late-onset relapsing-remitting multiple sclerosis.
Effects of Dalfampridine Extended-Release Tablets on 6-Minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-Blind, Placebo-Controlled Trial.
Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis.
No Regional Gray Matter Atrophy Differences between Pediatric- and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Eosinophilic Fasciitis Occurring under Treatment with Natalizumab for Multiple Sclerosis.
Patient perceptions of multiple sclerosis and its treatment.
Inflammatory Response and Chemokine Expression in the White Matter Corpus Callosum and Gray Matter Cortex Region During Cuprizone-Induced Demyelination.
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning.

Pages